Inventor · disambiguated record
John Tellis
Also filed as: TELLIS JOHN · TELLIS JOHN C
7 granted patents·2 pending applications·12 citations·filing 2018–2024
76Inventor score
Files withGENENTECH INC9
Top patents by PatentIndex Score
9 records- 0195US11566003B2Isoquinolines as inhibitors of HPK1GENENTECH INC·Filed 2020·Granted Jan 31, 2023·4 cites·31 claims
- 0290US10407424B2Naphthyridines as inhibitors of HPK1GENENTECH INC·Filed 2018·Granted Sep 10, 2019·5 cites·72 claims
- 0381US11034692B1Naphthyridines as inhibitors of HPK1GENENTECH INC·Filed 2019·Granted Jun 15, 2021·1 cites·20 claims
- 0480US11612606B28-aminoisoquinoline compounds and uses thereofGENENTECH INC·Filed 2019·Granted Mar 28, 2023·2 cites·29 claims
- 0562US2024228463A1Sodium channel inhibitors and methods of designing sameGENENTECH INC·Filed 2024·Application pending·0 cites
- 0654US2018282282A1Isoquinolines as inhibitors of hpk1GENENTECH INC·Filed 2018·Application pending·0 cites
- 0753US12473301B2Isoquinoline compounds for the treatment of cancerGENENTECH INC·Filed 2021·Granted Nov 18, 2025·0 cites·18 claims
- 0853US12378249B2Isoquinoline compounds and uses thereofGENENTECH INC·Filed 2021·Granted Aug 5, 2025·0 cites·25 claims
- 0953US12297210B2Naphthyridine compounds and uses thereofGENENTECH INC·Filed 2021·Granted May 13, 2025·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when John Tellis files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →